A detailed history of Gabelli Funds LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 100,000 shares of PACB stock, worth $193,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,000
Previous 100,000 -0.0%
Holding current value
$193,000
Previous $137,000 24.09%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$3.93 - $8.57 $32,626 - $71,148
-8,302 Reduced 7.67%
100,000 $581,000
Q2 2022

Aug 12, 2022

SELL
$4.02 - $10.43 $380,685 - $987,700
-94,698 Reduced 46.65%
108,302 $479,000
Q4 2021

Feb 11, 2022

BUY
$19.26 - $30.08 $3.91 Million - $6.11 Million
203,000 New
203,000 $4.15 Million
Q4 2020

Feb 05, 2021

SELL
$10.5 - $28.5 $2.9 Million - $7.87 Million
-276,000 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$3.61 - $9.87 $7.45 Million - $20.4 Million
-2,064,887 Reduced 88.21%
276,000 $2.72 Million
Q2 2020

Aug 13, 2020

SELL
$2.65 - $4.03 $71,550 - $108,810
-27,000 Reduced 1.14%
2,340,887 $8.08 Million
Q1 2020

May 14, 2020

SELL
$2.36 - $5.26 $169,945 - $378,777
-72,011 Reduced 2.95%
2,367,887 $7.25 Million
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $1.64 Million - $1.99 Million
-357,361 Reduced 12.78%
2,439,898 $12.5 Million
Q3 2019

Nov 01, 2019

SELL
$4.99 - $6.16 $301,825 - $372,593
-60,486 Reduced 2.12%
2,797,259 $14.4 Million
Q2 2019

Aug 02, 2019

SELL
$5.92 - $7.41 $250,777 - $313,895
-42,361 Reduced 1.46%
2,857,745 $17.3 Million
Q1 2019

May 02, 2019

BUY
$6.8 - $7.4 $7.86 Million - $8.55 Million
1,155,636 Added 66.25%
2,900,106 $21 Million
Q4 2018

Jan 30, 2019

BUY
$3.99 - $7.82 $6.96 Million - $13.6 Million
1,744,470 New
1,744,470 $12.9 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.